Nagatsu T - Search Results

1

A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.

Takubo H, Harada T, Hashimoto T, Inaba Y, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Yanagisawa N, Narabayashi H. Takubo H, et al. Among authors: nagatsu t. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S31-41. doi: 10.1016/s1353-8020(02)00122-0. Parkinsonism Relat Disord. 2003. PMID: 12735913

2

Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.

Suzuki K, Mizuno Y, Yamauchi Y, Nagatsu T, Mitsuo Y. Suzuki K, et al. Among authors: nagatsu t. J Neurol Sci. 1992 Jun;109(2):219-23. doi: 10.1016/0022-510x(92)90172-h. J Neurol Sci. 1992. PMID: 1353109

3

Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia.

Narabayashi H, Kondo T, Yokochi F, Nagatsu T. Narabayashi H, et al. Among authors: nagatsu t. Adv Neurol. 1987;45:593-602. Adv Neurol. 1987. PMID: 3103397 No abstract available.

4

Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.

Saitoh T, Mizuno Y, Nagatsu T, Yoshida M. Saitoh T, et al. Among authors: nagatsu t. Neurosci Lett. 1988 Oct 17;92(3):321-4. doi: 10.1016/0304-3940(88)90610-6. Neurosci Lett. 1988. PMID: 3200488

5

Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease.

Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Mogi M, et al. Among authors: nagatsu t. Neurosci Lett. 1995 Jun 30;193(2):129-32. doi: 10.1016/0304-3940(95)11686-q. Neurosci Lett. 1995. PMID: 7478158

6

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Mogi M, et al. Among authors: nagatsu t. Neurosci Lett. 1994 Jan 3;165(1-2):208-10. doi: 10.1016/0304-3940(94)90746-3. Neurosci Lett. 1994. PMID: 8015728

7

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T. Mogi M, et al. Among authors: nagatsu t. Neurosci Lett. 1996 Jun 14;211(1):13-6. doi: 10.1016/0304-3940(96)12706-3. Neurosci Lett. 1996. PMID: 8809836 Clinical Trial.

8

bcl-2 protein is increased in the brain from parkinsonian patients.

Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T. Mogi M, et al. Among authors: nagatsu t. Neurosci Lett. 1996 Sep 6;215(2):137-9. Neurosci Lett. 1996. PMID: 8888015

9

The soluble form of Fas molecule is elevated in parkinsonian brain tissues.

Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T. Mogi M, et al. Among authors: nagatsu t. Neurosci Lett. 1996 Dec 20;220(3):195-8. doi: 10.1016/s0304-3940(96)13257-2. Neurosci Lett. 1996. PMID: 8994226

10

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.

Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T. Mogi M, et al. Among authors: nagatsu t. Neurosci Lett. 1999 Jul 23;270(1):45-8. doi: 10.1016/s0304-3940(99)00463-2. Neurosci Lett. 1999. PMID: 10454142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters